In the last few years, a number of Western drugmakers have struck deals that will permit local manufacturing of their drugs in Saudi Arabia. U.S. drugmaker…

Sanofi is jumping into the Rituxan biosimilars fray in a potential $200 million-plus deal with JHL Biotech, putting the Taiwan-based drugmaker's new China…

Valeant's business relationships with its distributors are under scrutiny once again, with the latest probe focusing on the remarkable sales performance…

The massive CPhI show kicked off in Barcelona, Spain, on Tuesday with numbers that rival some small cities. An estimated 38,000 visitors from 150 countries…

China’s Zhejiang Hisun Pharmaceutical has gotten in progressively hotter water with the FDA, but its troubles have not kept it from striking deals globally…

Japan’s Fujifilm jumped into biologics contract manufacturing about 5 years ago by buying two plants from Merck & Co., when the U.S. drugmaker dropped that…

Merck KGaA wants to be a go-to company to help others develop and manufacture gene-related therapies and will expand its campus in Carlsbad, CA, by nearly 50%…

Despite a stumbling economy in recent years, Russia still holds a lot of appeal as an emerging market for drugmakers. Japan's Eisai is planning a major…

By year-end, the United Arab Emirates (UAE) can expect to have a new manufacturing plant producing drugs for the country as a Saudi drugmaker completes the…

Partnering